|
|
|
 |
|
|
| Spotlight on Signal Transduction Inhibitors: Basic Aspects and Therapeutic Implications |
|
| Molecular targets for therapy, signal transduction inhibition and imatinib FREE |
| N Muller-Bérat Killmann & J A McCubrey |
| Abstract | Full text | PDF |
|
| 1205 |
|
| Spotlight Imatinib: a model for signal transduction inhibitors FREE |
| A Hochhaus, J A McCubrey & N Muller-Bérat Killmann |
| Abstract | Full text | PDF |
|
| 1205 |
|
| Reviews |
|
| Tyrosine kinase fusion genes in chronic myeloproliferative diseases FREE |
| N C P Cross & A Reiter |
| Abstract | Full text | PDF |
|
| 1207 |
|
| Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective FREE |
| P La Rosée, M E O'Dwyer & B J Druker |
| Abstract | Full text | PDF |
|
| 1213 |
|
| Original Manuscripts |
|
| Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT) FREE |
| T Fischer, C Reifenrath, G R Hess, M T Corsetti, S Kreil, J Beck, P Meinhardt, G Beltrami, B Schuch, H Gschaidmeier, R Hehlmann, A Hochhaus, A Carella & C Huber |
| Abstract | Full text | PDF |
|
| 1220 |
|
| Spotlight on Chronic Lymphocytic Leukemia |
|
| Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis FREE |
| B Summersgill, P Thornton, S Atkinson, E Matutes, J Shipley, D Catovsky, R S Houlston & M R Yuille |
| Abstract | Full text | PDF |
|
| 1229 |
|
| Antigen expression patterns reflecting genotype of acute leukemias FREE |
O Hru ák & A Porwit-MacDonald |
| Abstract | Full text | PDF |
|
| 1233 |
|
| Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study FREE |
| J Takeuchi, T Kyo, K Naito, H Sao, M Takahashi, S Miyawaki, K Kuriyama, S Ohtake, F Yagasaki, H Murakami, N Asou, T Ino, T Okamoto, N Usui, M Nishimura, K Shinagawa, T Fukushima, H Taguchi, T Morii, S Mizuta, H Akiyama, Y Nakamura, T Ohshima & R Ohno |
| Abstract | Full text | PDF |
|
| 1259 |
|
| Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia FREE |
| C Rowntree, V Duke, P Panayiotidis, P Kotsi, G L Palmisano, A V Hoffbrand & L Foroni |
| Abstract | Full text | PDF |
|
| 1267 |
|
Signals mediated by Fc RIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells FREE |
| T Suzuki, E Coustan-Smith, K Mihara & D Campana |
| Abstract | Full text | PDF |
|
| 1276 |
|
| Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia FREE |
| K Nishii, N Katayama, H Miwa, M Shikami, E Usui, M Masuya, H Araki, F Lorenzo, T Ogawa, T Kyo, K Nasu, H Shiku & K Kita |
| Abstract | Full text | PDF |
|
| 1285 |
|
| Expression pattern of HOXB6 homeobox gene in myelomonocytic differentiation and acute myeloid leukemia FREE |
| A Giampaolo, N Felli, D Diverio, O Morsilli, P Samoggia, M Breccia, F Lo Coco, C Peschle & U Testa |
| Abstract | Full text | PDF |
|
| 1293 |
|
| Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia FREE |
| T Padró, R Bieker, S Ruiz, M Steins, S Retzlaff, H Bürger, T Büchner, T Kessler, F Herrera, J Kienast, C Müller-Tidow, H Serve, W E Berdel & R M Mesters |
| Abstract | Full text | PDF |
|
| 1302 |
|
| Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia FREE |
| L F Porrata, M R Litzow, A Tefferi, L Letendre, S Kumar, S M Geyer & S N Markovic |
| Abstract | Full text | PDF |
|
| 1311 |
|
| Optimized lentiviral transduction of erythroid precursors from healthy adults and patients with myelodysplastic syndromes FREE |
| T W Matthes, V Kindler, F Leuba, L E French, B Chapuis, P Beris & V Piguet |
| Abstract | Full text | PDF |
|
| 1319 |
|
| mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation FREE |
| P Ponsaerts, V F I Van Tendeloo, N Cools, A Van Driessche, F Lardon, G Nijs, M Lenjou, G Mertens, C Van Broeckhoven, D R Van Bockstaele & Z N Berneman |
| Abstract | Full text | PDF |
|
| 1324 |
|
| Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) FREE |
| J Almenara, R Rosato & S Grant |
| Abstract | Full text | PDF |
|
| 1331 |
|
| The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis FREE |
| C Ito, C Tecchio, E Coustan-Smith, T Suzuki, F G Behm, S C Raimondi, C-H Pui & D Campana |
| Abstract | Full text | PDF |
|
| 1344 |
|
| Haplotype study of microsatellites flanking the t(15;17) breakpoint in acute promyelocytic leukemia patients from North Portugal FREE |
| S Martins, F Trigo, L Azevedo, M J Silva, J E Guimaraes & A Amorim |
| Abstract | Full text | PDF |
|
| 1353 |
|
Biased Ig expression in hypermutated IgD multiple myelomas does not result from receptor revision FREE |
| M van der Burg, R J Bende, W M Aarts, A W Langerak, J J M van Dongen & C J M van Noesel |
| Abstract | Full text | PDF |
|
| 1358 |
|
| The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells FREE |
| N W C J van de Donk, M M J Kamphuis, H M Lokhorst & A C Bloem |
| Abstract | Full text | PDF |
|
| 1362 |
|
| Bio-Technical Methods Section (BTS) |
|
| T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis FREE |
| V H J van der Velden, J M Wijkhuijs, D C H Jacobs, E R van Wering & J J M van Dongen |
| Abstract | Full text | PDF |
|
| 1372 |
|
| Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry FREE |
J Trka, M Kalinová, O Hruák, J Zuna, O Krej í, J Mad o, P Sedláek, V Vávra, K Michalová, M Jaroová & J Star for Czech Paediatric Haematology Working Group |
| Abstract | Full text | PDF |
|
| 1381 |
|
| Spotlight Correspondence |
|
| Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 FREE |
| M K Andersen, J Pedersen-Bjergaard, L Kjeldsen, I H Dufva & K Brøndum-Nielsen |
| Abstract | Full text | PDF |
|
| 1390 |
|
| ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL) FREE |
| B Selle, C Bär, S Hecker, U Schmidt-Rohr, S Viehmann, K-M Debatin & D Reinhardt |
| Abstract | Full text | PDF |
|
| 1393 |
|
| Correspondence |
|
| The class II tumour suppressor gene RARRES3 maps to 11q12, not 11q23 FREE |
| R L Auer, F Bertoni, C Jones & F E Cotter |
| Abstract | Full text | PDF |
|
| 1396 |
|
| Response to Auer: the class II tumor-suppressor gene RARRES3 is expressed in B-CLL and down-regulated with disease progression FREE |
| A Garcia-Pardo |
| Abstract | Full text | PDF |
|
| 1396 |
|
| Response to Garcia-Pardo FREE |
| R L Auer |
| Abstract | Full text | PDF |
|
| 1397 |
|
| Reply to Auer FREE |
| A Garcia-Pardo |
| Abstract | Full text | PDF |
|
| 1397 |
|
|
|
| July 2002, Volume 16, Number 7 |
|
| <Previous Issue Next > |
